Dr. Robert Flavell, MD, PhD
Claim this profileUniversity of California, San Francisco
Studies Prostate Cancer
Studies Plasma Cell Neoplasm
3 reported clinical trials
5 drugs studied
Affiliated Hospitals
Clinical Trials Robert Flavell, MD, PhD is currently running
89Zr-DFO-YS5 Imaging
for Prostate Cancer
This trial is testing FOR46, a medicine that targets a protein on aggressive prostate cancer cells. It helps doctors see the cancer better using special scans. The study focuses on patients with hard-to-treat prostate cancer.
Recruiting1 award Phase 1
Radioactive Tracer Imaging
for Multiple Myeloma
This phase I trial tests the safety of \[89Zr\]DFO-YS5 positron emission tomography (PET) imaging and how well it works to detect CD46 positive cancer cells in patients with multiple myeloma. \[89Zr\]DFO-YS5 is an imaging agent called a radiopharmaceutical tracer. A radiopharmaceutical tracer uses a small amount of radioactive material that is injected into a vein to help image different areas of the body. \[89Zr\]DFO-YS5 targets a specialized protein called CD46, which is in certain multiple myeloma cancer cells, and \[89Zr\]DFO-YS5 PET scans may improve detection of multiple myeloma.
Recruiting1 award Phase 18 criteria
More about Robert Flavell, MD, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Robert Flavell, MD, PhD has experience with
- Hyperpolarized Bicarbonate (13C)
- Magnetic Resonance Imaging
- 89Zr-DFO-YS5
- YS5 Antibody
- Zirconium Zr 89-DFO-YS5
Breakdown of trials Robert Flavell, MD, PhD has run
Prostate Cancer
Plasma Cell Neoplasm
Multiple Myeloma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Flavell, MD, PhD specialize in?
Robert Flavell, MD, PhD focuses on Prostate Cancer and Plasma Cell Neoplasm. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Robert Flavell, MD, PhD currently recruiting for clinical trials?
Yes, Robert Flavell, MD, PhD is currently recruiting for 3 clinical trials in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Robert Flavell, MD, PhD has studied deeply?
Yes, Robert Flavell, MD, PhD has studied treatments such as Hyperpolarized Bicarbonate (13C), Magnetic Resonance Imaging, 89Zr-DFO-YS5.
What is the best way to schedule an appointment with Robert Flavell, MD, PhD?
Apply for one of the trials that Robert Flavell, MD, PhD is conducting.
What is the office address of Robert Flavell, MD, PhD?
The office of Robert Flavell, MD, PhD is located at: University of California, San Francisco, San Francisco, California 94143 United States. This is the address for their practice at the University of California, San Francisco.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.